D-1031-2018 Class III Terminated

Recalled by Renaissance Lakewood, LLC — Lakewood, NJ

FDA drug recall D-1031-2018 was initiated by Renaissance Lakewood, LLC on Jul 11, 2018 and is designated Class III. Reason for recall: Superpotent Drug and Failed Stability Specifications: lot out of specification for elevated sodium chloride and elevated water vapor. The recall status is terminated (terminated Mar 9, 2022). Affected quantity: 3000 bags.

Recall details

Product Type
Drugs
Report Date
Aug 8, 2018
Initiation Date
Jul 11, 2018
Termination Date
Mar 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3000 bags

Product description

Fluconazole Injection, USP, Iso-Osmotic Sodium Chloride Diluent, 400 mg in 200 mL (2 mg/mL), 200 mL Single Dose Flexible Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India; NDC 36000-003-06.

Reason for recall

Superpotent Drug and Failed Stability Specifications: lot out of specification for elevated sodium chloride and elevated water vapor.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot # A061213, Exp 09/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1031-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1031-2018. Report a data issue: hello@regdatalab.com.